法规知识库 · EMA 集中审评
Bemfola
follitropin alfa · EMEA/H/C/002615 · 已授权
获批上市许可
2014-03-26
欧委会决定日
2026-09-14
持有人 / 申请人
Gedeon Richter Plc.
终止日期字段
无
从产品到官方文件
文件记录
7
官方索引 7
EPAR / 审评
5
assessment / overview 等
产品信息
2
PI / presentations
其他
0
RMP / PIP 等
ATC:G03GA05
治疗领域:Anovulation
药理分类:Sex hormones and modulators of the genital system
修订号:13 · 最新影响 PI 的程序:VR/0000357170
适应症(原文):In adult women: anovulation (including polycystic ovarian disease, PCOD) in women who have been unresponsive to treatment with clomiphene citrate; stimulation of multifollicular development in patients undergoing superovulation for assisted reproductive technologies (ART) such as in vitro fertilisation (IVF), gamete intra-fallopian transfer (GIFT) and zygote intra-fallopian transfer (ZIFT); follitropin alfa in association with a luteinising hormone (LH) preparation is recommended for the stimulation of follicular development in women with severe LH and FSH deficiency. In clinical trials these patients were defined by an endogenous serum LH level < 1.2 IU/l. In adult men: follitropin alfa is indicated for the stimulation of spermatogenesis in men who have congenital or acquired hypogonadotrophic hypogonadism with concomitant human Chorionic Gonadotrophin (hCG) therapy.
关键日期时间轴
来自 EMA medicines JSON 日期字段;缺失字段不展示,不补推结论。
2026-09-14 · 欧委会决定
2014-03-26 · 获批上市许可
2014-01-22 · CHMP 意见通过
说明书、EPAR 与其他文件
仅展示 EMA 官方 document_url;本站不下载或镜像 PDF。
EPAR / 审评资料
- 打开官方文件 ↗
Bemfola : EPAR - Procedural steps taken and scientific information after authorisation
procedural-steps-after · 2026-10-13
- 打开官方文件 ↗
Bemfola : EPAR - Procedural steps taken and scientific information after authorisation (archive)
procedural-steps-after · 2024-01-12
- 打开官方文件 ↗
Bemfola : EPAR - Public assessment report
assessment-report · 2014-07-22 · EMA/65507/2013 Rev. 1
- 打开官方文件 ↗
Bemfola : EPAR - Risk-management-plan summary
rmp-summary · 2014-05-16 · EMA/83300/2014
- 打开官方文件 ↗
Bemfola : EPAR - Summary for the public
overview · 2014-05-16 · EMA/CHMP/50313/2014
数据来自 EMA 官方 JSON;最终以 EMA / 欧委会文件为准。本页不自动给出安全或非安全结论。